Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 9, Issue 1 (2020)

Profile of resistance and serotypage of Pseudomonas aeruginosa isolated of African giant’s snails

Author(s):
Kouassi Eugene Koffi, Nguessan Daniel Saraka, Kan Stéphane Kouassi, Fabrice Gnali and Mireille Dosso
Abstract:
Pseudomonas aeruginosa was sought by feet swabbing of 201 specimens belonging to the 3 African giant snail species present in Ivory Cost (Achatina fulica, Achatina achatina and Archachatina ventricosa). These snails were collected on the markets, and environment. The sensitivity to antibiotics Antibiotic susceptibility of isolated bacteria was achieved by the standard method of diffusion in agar media. Then the serotypage of these strains was carried out by the technique of agglutination on slide using specific polyvalent and monovalent antiserums, according to the manufacturer's protocol (Bio-rad®).
The aim of this study was to investigate the antibiotic resistance profile and serotypes of colonizing snails of Pseudomonas aeruginosa in order to use this bacterium as a biomarker used as an indicator of the medical quality of these snails. The results show resistance rates of 52.7% for tircacillin, 13.8% for tircacillin + clavulanic acid, 05% for cesfulodin and 0% for piperacillin, imipenem and ceftazidim. These rates are based on collection sites and snail species. After serotypage these strains, five serotypes were obtained: O4 (30.4%); O1 (26%); O6 (17.3%); O11 (13.4%); O15 (13.4%). Diversity was also observed in the distribution of serotypes according to collection media and snail species as well as in the resistance of these serotypes to different antibiotic molecules.
Pages: 135-138  |  692 Views  83 Downloads


The Pharma Innovation Journal
How to cite this article:
Kouassi Eugene Koffi, Nguessan Daniel Saraka, Kan Stéphane Kouassi, Fabrice Gnali, Mireille Dosso. Profile of resistance and serotypage of Pseudomonas aeruginosa isolated of African giant’s snails. Pharma Innovation 2020;9(1):135-138.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter